NVS - Novartis AG
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$146.00
DETAILS
HIGH:
$156.00
LOW:
$136.00
MEDIAN:
$146.00
CONSENSUS:
$146.00
DOWNSIDE:
5.16%
About Novartis AG (https://www.novartis.com)
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
Key Executives
| NAME | TITLE | DOB | SALARY |
|---|---|---|---|
| Vasant Narasimhan | Chief Executive Officer | 1976 | $9,032,521 USD |
| Victor Bulto | President of US | 1978 | $3,987,535 USD |
| Mukul Mehta | Chief Financial Officer | 1973 | $3,772,334 USD |
| Patrick Horber | President of International | 1970 | $3,262,856 USD |
| Karen L. Hale | Chief Legal & Compliance Officer | 1968 | $2,555,202 USD |
| Steffen Lang | President of Operations | 1967 | $2,548,062 USD |
| Robert Kowalski | Chief People & Organization Officer | 1968 | $2,291,074 USD |
| Evan Beckman | Global Head of Translational Medicine at Novartis Institute for BioMedical Research | – | – |
| Paul Penepent | Head of Group Financial Reporting and Accounting | – | – |
| Sloan Simpson | Global Head of Investor Relations | – | – |